MapLight Therapeutics, Inc. (MapLight) (Nasdaq: MPLT) today announced an update to the expected timing of topline results for its ongoing Phase 2 ZEPHYR and IRIS clinical studies, which are ...
Clinical Trials Arena on MSN
Ascletis receives FDA approval for diabetes mellitus clinical trial of ASC30
Ascletis Pharma has received investigational new drug (IND) clearance from the US Food and Drug Administration (FDA) to begin ...
ClostraBio, a biotechnology company developing next-generation probiotics to support gut health, today announced the full ...
Corvus Pharmaceuticals (CRVS) confirms the planned announcement of the results from cohort 4 of the randomized, blinded, placebo-controlled Phase ...
Telitacicept, a dual inhibitor of the cytokines B-lymphocyte stimulator and a proliferation-inducing ligand, showed efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback